Cormorant Asset Management, LP
Net seller this quarter
$1.95B
50
-$270M
59.2%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 PRAX | $214M | 10.98% | 2.29% | -27.7% | Q4 2020 |
 BBOT | $136M | 6.98% | 22.32% | Not reported | Q1 2024 |
 PBLS | $126M | 6.47% | 3.79% | New | Q2 2026 |
 RAPP | $111M | 5.67% | 5.54% | -10.1% | Q2 2024 |
 ERAS | $110M | 5.63% | 1.92% | +3.5% | Q3 2021 |
 EWTX | $102M | 5.23% | 2.33% | -23.0% | Q1 2021 |
 EYPT | $100M | 5.13% | 8.24% | -15.3% | Q1 2023 |
 ALMS | $92.5M | 4.74% | Not reported | -16.8% | Q2 2024 |
 ABVX | $90M | 4.61% | 0.86% | -11.2% | Q4 2023 |
 DNTH | $73.1M | 3.75% | 1.37% | -21.1% | Q1 2026 |
 DRUG | $63.2M | 3.24% | 11.79% | -15.0% | Q4 2024 |
 MLTX | $62.4M | 3.20% | 4.35% | -28.5% | Q4 2020 |
 BIOA | $58.6M | 3.00% | 5.22% | -17.3% | Q3 2024 |
 ORKA | $50.8M | 2.60% | 0.87% | Not reported | Q3 2025 |
 ANL | $45.7M | 2.34% | Not reported | +37.3% | Q1 2026 |
 BBIO | $41M | 2.10% | 0.28% | -35.3% | Q2 2019 |
 TNGX | $40.6M | 2.08% | 0.77% | -8.8% | Q3 2021 |
 BHVN | $38.8M | 1.99% | 1.73% | +48.3% | Q4 2017 |
 AGMB | $32M | 1.64% | 7.22% | Not reported | Q1 2026 |
 MBX | $30.4M | 1.56% | 1.15% | -50.9% | Q3 2024 |
 CLYM | $27.5M | 1.41% | 3.67% | New | Q2 2026 |
 OLMA | $26.9M | 1.38% | 2.46% | -44.9% | Q4 2020 |
 DMRA | $26M | 1.33% | 1.62% | -34.4% | Q1 2026 |
 PHVS | $25.9M | 1.33% | 1.15% | -25.0% | Q1 2021 |
 CRBP | $22M | 1.13% | 12.56% | Not reported | Q2 2016 |
 SYRE | $20M | 1.02% | 0.26% | Not reported | Q4 2023 |
 DFTX | $18.8M | 0.96% | 0.30% | New | Q2 2026 |
 NAMS | $16.9M | 0.87% | 0.43% | -47.4% | Q1 2024 |
 ROIV | $16.8M | 0.86% | 0.07% | -36.7% | Q1 2026 |
 CABA | $15.6M | 0.80% | 3.07% | -9.1% | Q4 2019 |
 HLXC | $13.8M | 0.71% | Not reported | Not reported | Q1 2026 |
 ASND | $13.3M | 0.68% | 0.08% | -47.4% | Q1 2015 |
 KLRA | $12.1M | 0.62% | 0.42% | New | Q2 2026 |
 INSM | $8M | 0.41% | 0.03% | -60.5% | Q1 2020 |
 FTH | $7.66M | 0.39% | 3.98% | +235.8% | Q1 2026 |
 ELVN | $7.61M | 0.39% | 0.20% | Not reported | Q1 2023 |
 TARS | $6.29M | 0.32% | 0.23% | -55.6% | Q4 2020 |
 IBIO | $6.25M | 0.32% | 6.41% | New | Q2 2026 |
| CRNX | $4.68M | 0.24% | 0.12% | -50.0% | Q3 2023 |
 ARQT | $4.59M | 0.24% | 0.14% | -61.1% | Q3 2022 |
 ARWR | $4.08M | 0.21% | 0.04% | -50.0% | Q4 2013 |
 GPCR | $4.03M | 0.21% | 0.04% | -57.1% | Q1 2023 |
 RACC | $3.96M | 0.20% | Not reported | New | Q2 2026 |
 COGT | $3.87M | 0.20% | 0.06% | -50.0% | Q2 2022 |
 ALT | $3.8M | 0.19% | 0.64% | Not reported | Q2 2022 |
 AMLX | $3.59M | 0.18% | 0.18% | -42.9% | Q3 2022 |
 ODTX | $3.27M | 0.17% | 0.37% | New | Q2 2026 |
 PCVX | $2.91M | 0.15% | 0.03% | -50.0% | Q4 2022 |
 BOLD | $2.5M | 0.13% | 4.45% | New | Q2 2026 |
 QNCX | $100K | 0.01% | 0.54% | New | Q2 2026 |
| Q1 2026 | |||||
| PRAX | $285M | 14.33% | 3.18% | -6.8% | Q4 2020 |
| BBOT | $160M | 8.04% | 22.32% | Not reported | Q1 2024 |
| EYPT | $107M | 5.35% | 9.90% | Not reported | Q1 2023 |
| EWTX | $103M | 5.16% | 3.03% | -0.8% | Q1 2021 |
| ERAS | $93.8M | 4.71% | 1.87% | Not reported | Q3 2021 |
| RAPP | $92.5M | 4.65% | 6.19% | -2.3% | Q2 2024 |
| ALMS | $87M | 4.37% | Not reported | +8.6% | Q2 2024 |
| ABVX | $84.6M | 4.25% | 0.97% | -43.7% | Q4 2023 |
| MLTX | $83.5M | 4.19% | 8.50% | +2.9% | Q4 2020 |
| DNTH | $79.7M | 4.00% | 1.74% | New | Q1 2026 |
| DRUG | $77.3M | 3.88% | 13.87% | Not reported | Q4 2024 |
| BBIO | $63.1M | 3.17% | 0.43% | -29.2% | Q2 2019 |
| OLMA | $58.1M | 2.92% | 4.47% | +41.8% | Q4 2020 |
| BIOA | $50.6M | 2.54% | 6.51% | +41.7% | Q3 2024 |
| CNTA | $41.7M | 2.09% | 0.68% | -20.8% | Q2 2021 |
| DMRA | $39.5M | 1.98% | 2.53% | New | Q1 2026 |
| MBX | $33.4M | 1.68% | 2.35% | Not reported | Q3 2024 |
| INSM | $31.1M | 1.56% | 0.09% | -30.9% | Q1 2020 |
| NAMS | $30.4M | 1.53% | 0.81% | -5.0% | Q1 2024 |
| TNGX | $29.8M | 1.50% | 0.99% | Not reported | Q3 2021 |
| PHVS | $28.3M | 1.42% | 1.53% | -7.7% | Q1 2021 |
| ORKA | $26.2M | 1.31% | 1.06% | Not reported | Q3 2025 |
| AGMB | $25.9M | 1.30% | 7.22% | New | Q1 2026 |
 MAZE | $22.4M | 1.12% | 1.51% | New | Q1 2026 |
| CRBP | $22M | 1.11% | 13.22% | Not reported | Q2 2016 |
| ASND | $21.7M | 1.09% | 0.15% | -5.0% | Q1 2015 |
| ROIV | $20.8M | 1.04% | 0.10% | New | Q1 2026 |
| ANL | $20.1M | 1.01% | Not reported | New | Q1 2026 |
| TERN | $15.8M | 0.79% | 0.26% | New | Q1 2026 |
| TARS | $15.8M | 0.79% | 0.52% | -10.0% | Q4 2020 |
| BHVN | $14.9M | 0.75% | 1.17% | +17500.0% | Q4 2017 |
| CABA | $14.8M | 0.74% | 4.94% | +25.0% | Q4 2019 |
| HLXC | $13.2M | 0.66% | Not reported | New | Q1 2026 |
| ARQT | $10.6M | 0.53% | 0.36% | -10.0% | Q3 2022 |
| FTH | $9.65M | 0.48% | 22.85% | New | Q1 2026 |
| CRNX | $9.08M | 0.46% | 0.24% | -16.7% | Q3 2023 |
 ZURA | $8.63M | 0.43% | 1.53% | New | Q1 2026 |
 AXSM | $8.45M | 0.42% | 0.10% | -33.3% | Q4 2019 |
| GPCR | $8.44M | 0.42% | 0.08% | Not reported | Q1 2023 |
| COGT | $7.7M | 0.39% | 0.12% | -11.1% | Q2 2022 |
 GLUE | $6.58M | 0.33% | 0.47% | Not reported | Q2 2021 |
| ARWR | $6.27M | 0.31% | 0.07% | Not reported | Q4 2013 |
| PCVX | $5.81M | 0.29% | 0.07% | -20.0% | Q4 2022 |
| AMLX | $4.87M | 0.24% | 0.32% | -12.5% | Q3 2022 |
 RLYB | $3.59M | 0.18% | 7.56% | New | Q1 2026 |
 CNTX | $1.39M | 0.07% | 0.58% | New | Q1 2026 |
| Q4 2025 | |||||
| PRAX | $280M | 12.95% | 3.77% | -5.0% | Q4 2020 |
| BBOT | $224M | 10.35% | 22.35% | Not reported | Q1 2024 |
| ABVX | $182M | 8.42% | 1.72% | -30.8% | Q4 2023 |
| EYPT | $151M | 6.98% | 9.98% | -0.7% | Q1 2023 |
| RAPP | $91.9M | 4.25% | 6.34% | -5.2% | Q2 2024 |
| BBIO | $91.8M | 4.24% | 0.62% | -14.3% | Q2 2019 |
| DRUG | $82.7M | 3.82% | 13.87% | Not reported | Q4 2024 |
| EWTX | $81.5M | 3.77% | 3.09% | -18.1% | Q1 2021 |
| OLMA | $68.8M | 3.18% | 3.38% | Not reported | Q4 2020 |
| MLTX | $57.4M | 2.65% | 8.26% | +118.4% | Q4 2020 |
| INSM | $47.9M | 2.21% | 0.13% | -36.1% | Q1 2020 |
 ENGN | $36.1M | 1.67% | 5.97% | +72.2% | Q1 2024 |
| ALMS | $35.5M | 1.64% | Not reported | +69.3% | Q2 2024 |
| MBX | $35.3M | 1.63% | 2.49% | -8.6% | Q3 2024 |
| NAMS | $35.1M | 1.62% | 0.87% | -54.0% | Q1 2024 |
| CNTA | $33.1M | 1.53% | 0.89% | -31.2% | Q2 2021 |
| PHVS | $30.1M | 1.39% | 1.66% | -20.6% | Q1 2021 |
| BIOA | $27M | 1.25% | 5.46% | -4.7% | Q3 2024 |
| ASND | $21.3M | 0.99% | 0.16% | Not reported | Q1 2015 |
| TARS | $20.5M | 0.95% | 0.59% | -16.7% | Q4 2020 |
| CRBP | $19.1M | 0.88% | 13.32% | -1.3% | Q2 2016 |
 GHRS | $16.5M | 0.76% | 2.10% | -32.2% | Q2 2021 |
| ORKA | $16.2M | 0.75% | 1.09% | Not reported | Q3 2025 |
| ARQT | $14.5M | 0.67% | 0.41% | -35.5% | Q3 2022 |
| CRNX | $14M | 0.65% | 0.31% | -25.0% | Q3 2023 |
| AXSM | $13.7M | 0.63% | 0.15% | -25.0% | Q4 2019 |
| CABA | $9.64M | 0.45% | 4.38% | -12.0% | Q4 2019 |
 JANX | $8.97M | 0.41% | 1.08% | -23.5% | Q1 2024 |
| COGT | $7.99M | 0.37% | 0.14% | Not reported | Q2 2022 |
| PCVX | $5.77M | 0.27% | 0.10% | -28.6% | Q4 2022 |
| AMLX | $4.83M | 0.22% | 0.36% | -20.0% | Q3 2022 |
| BHVN | $113K | 0.01% | 0.01% | Not reported | Q4 2017 |
| Q3 2025 | |||||
| BBOT | $207M | 14.29% | 22.57% | +514.6% | Q1 2024 |
| ABVX | $166M | 11.42% | 3.08% | -8.5% | Q4 2023 |
| EYPT | $119M | 8.18% | 11.97% | Not reported | Q1 2023 |
| RAPP | $94.8M | 6.54% | 6.70% | +8.6% | Q2 2024 |
| BBIO | $72.7M | 5.02% | 0.73% | -12.5% | Q2 2019 |
| EWTX | $65M | 4.49% | 3.79% | -5.7% | Q1 2021 |
| DRUG | $64.3M | 4.43% | 13.87% | Not reported | Q4 2024 |
| ACLX | $63.6M | 4.39% | 1.34% | -3.1% | Q2 2022 |
| INSM | $61.9M | 4.27% | 0.20% | -20.4% | Q1 2020 |
| NAMS | $61.9M | 4.27% | 1.92% | Not reported | Q1 2024 |
| PRAX | $53M | 3.66% | 4.72% | -38.5% | Q4 2020 |
| CNTA | $46.7M | 3.22% | 1.43% | -7.7% | Q2 2021 |
| PHVS | $34M | 2.35% | 2.51% | -6.3% | Q1 2021 |
| CRBP | $30M | 2.07% | 18.95% | Not reported | Q2 2016 |
| GHRS | $27.4M | 1.89% | 3.68% | -4.6% | Q2 2021 |
 CGON | $25.2M | 1.74% | 0.80% | Not reported | Q1 2024 |
 KRRO | $22.3M | 1.54% | 4.95% | Not reported | Q4 2023 |
| MBX | $21.4M | 1.48% | 2.74% | +75.0% | Q3 2024 |
| MTSR | $20.9M | 1.44% | 0.38% | Not reported | Q1 2025 |
| JANX | $20.8M | 1.43% | 1.41% | -43.3% | Q1 2024 |
| TARS | $17.8M | 1.23% | 0.71% | Not reported | Q4 2020 |
| CRNX | $16.7M | 1.15% | 0.42% | Not reported | Q3 2023 |
| ENGN | $15.9M | 1.10% | 4.54% | Not reported | Q1 2024 |
| ARQT | $14.6M | 1.01% | 0.64% | -22.5% | Q3 2022 |
| MLTX | $14.3M | 0.99% | 3.78% | -76.5% | Q4 2020 |
| RNAM | $13.1M | 0.90% | 0.20% | +50.0% | Q2 2020 |
| BIOA | $12.6M | 0.87% | 5.97% | Not reported | Q3 2024 |
| AXSM | $12.1M | 0.84% | 0.20% | Not reported | Q4 2019 |
| CABA | $11.7M | 0.81% | 5.19% | Not reported | Q4 2019 |
| ORKA | $10.3M | 0.71% | 1.10% | New | Q3 2025 |
| ALMS | $8.57M | 0.59% | Not reported | Not reported | Q2 2024 |
 BMEA | $7.21M | 0.50% | 6.00% | Not reported | Q2 2021 |
| AMLX | $6.8M | 0.47% | 0.46% | Not reported | Q3 2022 |
| PCVX | $6.3M | 0.43% | 0.13% | Not reported | Q4 2022 |
| ELVN | $4.09M | 0.28% | 0.34% | Not reported | Q1 2023 |
| BHVN | $150K | 0.01% | 0.01% | Not reported | Q4 2017 |